ClearPoint Neuro
CLPT
50 hedge funds and large institutions have $65.6M invested in ClearPoint Neuro in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.
4,725% more call options, than puts
Call options by funds: $579K | Put options by funds: $12K
217% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 6
200% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 6
81% more capital invested
Capital invested by funds: $36.1M → $65.6M (+$29.4M)
28% more funds holding
Funds holding: 39 → 50 (+11)
1.53% more ownership
Funds ownership: 13.48% → 15.01% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.82M |
| 2 |
KC
Kepos Capital
New York
|
+$2.68M |
| 3 |
Millennium Management
New York
|
+$2.49M |
| 4 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$2.35M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
-$3.34M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$1.68M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$926K |
| 4 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$796K |
| 5 |
6CM
683 Capital Management
New York
|
-$329K |
CLPT Hedge Fund Activity: Q1 2021 in Review
50 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q1 2021, worth a combined $65.6M — up 81% from $36.1M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CLPT positions and 6 closed out — a net gain of 13 holders — while 18 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $5.82M. The largest seller was CM Management, exiting entirely with an estimated $3.34M sold.
- 50 institutional investors held ClearPoint Neuro (CLPT) as of Q1 2021, up from 39 in Q4 2020.
- Funds reported $65.6M of ClearPoint Neuro stock for Q1 2021, up 81% quarter-over-quarter.
- 19 funds opened new ClearPoint Neuro positions in Q1 2021 and 6 closed out, a net change of +13 holders.
- The largest ClearPoint Neuro buyer in Q1 2021 was BlackRock, an estimated $5.82M added.
- The largest ClearPoint Neuro seller in Q1 2021 was CM Management, an estimated $3.34M sold.
Based on aggregated 13F filings for Q1 2021.